Atlas FDA

Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account

Axis-Shield Diagnostics, Ltd. — Predicate Candidate Screening

24 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

117 daysmedian FDA review time
270 days90th percentile
24clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K253539Alere NT-proBNP for Alinity iAxis-Shield Diagnostics, Ltd.2026-02-18970
K241176Alere NT-proBNP for Alinity i Reagent KitAxis-Shield Diagnostics, Ltd.2025-01-162620
K233541ARCHITECT Active-B12 (Holotranscobalamin)Axis-Shield Diagnostics, Ltd.2024-07-312710
K172133ADVIA Centaur Active-B12 (Holotranscobalamin) (AB12) AssayAxis-Shield Diagnostics, Ltd.2017-10-271050
K121946AXIS-SHIELD ACVTIVE-B12Axis-Shield Diagnostics, Ltd.2013-03-222620
K121842ARCHITECT HBA1C, ARCHITECT HBA1C, AND ARCHITECT HBA1CAxis-Shield Diagnostics, Ltd.2012-12-121700
K112790AXIS-SHIELD 3-REAGENT HOMOCYSTEINE ASSAY FOR SYNCHRONAxis-Shield Diagnostics, Ltd.2012-05-072240
K112443ARCHITECT ACTIVE B-12 (HOLOTRANSCOBALAMIN)Axis-Shield Diagnostics, Ltd.2011-12-191170
K110296AXIS-SHIELD ANTI-CCPAxis-Shield Diagnostics, Ltd.2011-08-181980
K083868ARCHITECT ANTI-CCP (100 TEST), ARCHITECT ANTI-CCP (500 TEST)Axis-Shield Diagnostics, Ltd.2009-09-252701
K083222AXIS-SHIELD LIQUID STABLE (LS) 2-PART HOMOCYSTEINE REAGENT, Axis-Shield Diagnostics, Ltd.2009-07-312701
K073640ARCHITECT HOMOCYSTEINE REAGENTS, CALIBRATORS AND CONTROLSAxis-Shield Diagnostics, Ltd.2008-04-241200
K072686AXSYM HBA1C REAGENTS, AXSYM HBA1C CALIBRATORS, AXSYM HBA1C CAxis-Shield Diagnostics, Ltd.2008-03-171750
K063347AXSYM ANTI-CCP REAGENT, STANDARD CALIBRATOR AND CONTROL KITSAxis-Shield Diagnostics, Ltd.2007-03-201340
K062467AXSYM HOLO TC REAGENT KIT, MODEL 3L83-20; STANDARD CALIBRATOAxis-Shield Diagnostics, Ltd.2006-11-22900
K041866ABBOTT AXSYM TESTOSTERONE MICROPARTICLE ENZYME IMMUNOASSAY (Axis-Shield Diagnostics, Ltd.2004-09-29820
K033606ABBOTT AXSYM B-TYPE NATRIURETIC PEPTIDE (BNP) MICROPARTICLE Axis-Shield Diagnostics, Ltd.2004-01-30740
K031177DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100MAxis-Shield Diagnostics, Ltd.2003-06-19660
K023285DIASTAT ANTI CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) ELISAAxis-Shield Diagnostics, Ltd.2002-10-09231
K021516DIASTAT ANTI CYCLIC CITRULLINATED PEPTIDE ELISA, MODEL FCCP Axis-Shield Diagnostics, Ltd.2002-07-23741
K020687DIASTAT ANTI-THYROID PEROXIDASE ELISA MODEL #300Axis-Shield Diagnostics, Ltd.2002-05-02590
K020349ABBOTT AXSYM ANTI-THYROGLOBULIN, MODELS 5F5B COMPRISING STANAxis-Shield Diagnostics, Ltd.2002-05-02870
K020348ABBOTT AXSYM ANTI-THYROID-PEROXIDASE, MODELS5F57 COMPRISING Axis-Shield Diagnostics, Ltd.2002-05-02870
K020156DIASTAT TOTAL ANTI-CARDIOLIPIN, MODEL FCAR 100TAxis-Shield Diagnostics, Ltd.2002-03-06480

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda